These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9436811)

  • 1. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine.
    Pieper GM; Siebeneich W
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):734-8. PubMed ID: 9436811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals.
    Pieper GM; Langenstroer P; Siebeneich W
    Cardiovasc Res; 1997 Apr; 34(1):145-56. PubMed ID: 9217884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction.
    Pieper GM; Siebeneich W; Roza AM; Jordan M; Adams MB
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):741-5. PubMed ID: 8961070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with the 21-aminosteroid U74389F, an inhibitor of lipid peroxidation, does not prevent diabetic endothelial dysfunction.
    Pieper GM; Jordan M; Roza AM
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):435-40. PubMed ID: 9310271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction.
    Pieper GM; Dembny K; Siebeneich W
    Diabetologia; 1998 Oct; 41(10):1220-6. PubMed ID: 9794111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats.
    Csanyi G; Lepran I; Flesch T; Telegdy G; Szabo G; Mezei Z
    Pharmacol Rep; 2007; 59(4):447-55. PubMed ID: 17901574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species.
    Karasu C
    Eur J Pharmacol; 2000 Mar; 392(3):163-73. PubMed ID: 10762670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction.
    Pieper GM; Siebeneich W
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):101-5. PubMed ID: 9676728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic transplantation reverses endothelial dysfunction in experimental diabetes mellitus.
    Pieper GM; Adams MB; Roza AM
    Surgery; 1998 Jan; 123(1):89-95. PubMed ID: 9457228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes.
    Pieper GM; Jordan M; Adams MB; Roza AM
    Diabetes; 1995 Sep; 44(9):1106-13. PubMed ID: 7657036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starch-deferoxamine conjugate inhibits hepatocyte Ca2+ uptake during hemorrhagic shock and resuscitation.
    Rose S; Pizanis A; Silomon M
    J Trauma; 2000 Aug; 49(2):291-6; discussion 296-7. PubMed ID: 10963542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an extracellular metal chelator on neurovascular function in diabetic rats.
    Cameron NE; Cotter MA
    Diabetologia; 2001 May; 44(5):621-8. PubMed ID: 11380081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.
    Pieper GM
    Diabetologia; 1999 Feb; 42(2):204-13. PubMed ID: 10064101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction.
    Pieper GM; Siebeneich W
    Eur J Pharmacol; 2000 Sep; 403(1-2):129-32. PubMed ID: 10969153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature.
    Rodríguez-Mañas L; Angulo J; Vallejo S; Peiró C; Sánchez-Ferrer A; Cercas E; López-Dóriga P; Sánchez-Ferrer CF
    Diabetologia; 2003 Apr; 46(4):556-66. PubMed ID: 12739028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats.
    Roza AM; Slakey DP; Pieper GM; Van Ye TM; Moore-Hilton G; Komorowski RA; Johnson CP; Hedlund BE; Adams MB
    J Lab Clin Med; 1994 Apr; 123(4):556-60. PubMed ID: 7511676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.
    Pieper GM
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):8-15. PubMed ID: 9007664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-acting parenteral iron chelator, hydroxyethyl starch-deferoxamine, fails to protect against alcohol-induced liver injury in rats.
    Sadrzadeh SM; Hallaway PE; Nanji AA
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1038-42. PubMed ID: 9023321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine.
    Rosenthal RE; Chanderbhan R; Marshall G; Fiskum G
    Free Radic Biol Med; 1992; 12(1):29-33. PubMed ID: 1371490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.